{"success":true,"data":{"pressRelease":{"id":"20720","rtpr_id":"nACSPLw9Fa","ticker":"MEDP","exchange":"NASDAQ","all_tickers":["MEDP"],"title":"MEDP INVESTOR ALERT:  Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","published_at":"2026-05-05T11:00:02.300Z","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 5,\n2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst Medpace Holdings, Inc. (NASDAQ:MEDP) and certain of its officers.\n(https://app.accessnewswire.com/imagelibrary/d32d4cdc-ab77-48aa-801b-56f91ce05e71/image.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Medpace securities between April\n22, 2025 and February 9, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/MEDP.\n(https://bgandg.com/MEDP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=MEDP)\n\nMedpace Case Details\n\nThe Complaint alleges that, throughout the Class Period, Defendants made\nmaterially false and misleading statements and/or failed to disclose that:\n1.\nMedpace's public statements regarding its expected book-to-bill ratio for the\nfourth quarter and second half of fiscal year 2025 lacked a reasonable basis;\n2.\nDefendants repeatedly portrayed an overly optimistic book-to-bill ratio of\napproximately 1.15 during earnings calls and other public communications,\ndespite contrary internal information; and\n3.\nas a result, Defendants' statements about the Company's business, operations,\nand financial prospects were materially false and misleading at all relevant\ntimes.\n\nWhat's Next for Medpace Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/MEDP.\n(https://bgandg.com/MEDP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=MEDP)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in Medpace you have until June 5,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to Medpace Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Medpace Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/medp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1155651)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nACSPLw9Fa","title":"MEDP INVESTOR ALERT:  Bronstein, Gewirtz and Grossman, LLC Announces that Medpace Holdings, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!","author":"ACCESSWIRE","ticker":"MEDP","created":"2026-05-05T11:00:02.300Z","tickers":["MEDP"],"exchange":"NASDAQ","article_body":"NEW YORK CITY, NY / ACCESS Newswire (https://www.accessnewswire.com/) / May 5,\n2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized\ninvestor-rights law firm, announces that a class action lawsuit has been filed\nagainst Medpace Holdings, Inc. (NASDAQ:MEDP) and certain of its officers.\n(https://app.accessnewswire.com/imagelibrary/d32d4cdc-ab77-48aa-801b-56f91ce05e71/image.png)\nThis lawsuit seeks to recover damages against Defendants for alleged\nviolations of the federal securities laws on behalf of all persons and\nentities that purchased or otherwise acquired Medpace securities between April\n22, 2025 and February 9, 2026, both dates inclusive (the \"Class Period\"). Such\ninvestors are encouraged to join this case by visiting the firm's site:\nbgandg.com/MEDP.\n(https://bgandg.com/MEDP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=MEDP)\n\nMedpace Case Details\n\nThe Complaint alleges that, throughout the Class Period, Defendants made\nmaterially false and misleading statements and/or failed to disclose that:\n1.\nMedpace's public statements regarding its expected book-to-bill ratio for the\nfourth quarter and second half of fiscal year 2025 lacked a reasonable basis;\n2.\nDefendants repeatedly portrayed an overly optimistic book-to-bill ratio of\napproximately 1.15 during earnings calls and other public communications,\ndespite contrary internal information; and\n3.\nas a result, Defendants' statements about the Company's business, operations,\nand financial prospects were materially false and misleading at all relevant\ntimes.\n\nWhat's Next for Medpace Investors?\n\nA class action lawsuit has already been filed. If you wish to review a copy of\nthe Complaint, you can visit the firm's site: bgandg.com/MEDP.\n(https://bgandg.com/MEDP/?utm_source=accesswire&utm_medium=pressrelease&utm_campaign=MEDP)\nor you may contact Peretz Bronstein, Esq. or his Client Relations Manager,\nNathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911\n(tel:+9175900911). If you suffered a loss in Medpace you have until June 5,\n2026, to request that the Court appoint you as lead plaintiff. Your ability to\nshare in any recovery doesn't require that you serve as lead plaintiff.\n\nNo Cost to Medpace Investors\n\nWe, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on\na contingency fee basis. That means we will ask the court to reimburse us for\nout-of-pocket expenses and attorneys' fees, usually a percentage of the total\nrecovery, only if we are successful.\n\nWhy Bronstein, Gewirtz & Grossman, LLC for Medpace Securities Class Action?\n\nBronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that\nrepresents investors in securities fraud class actions and shareholder\nderivative suits. Our firm has recovered hundreds of millions of dollars for\ninvestors nationwide. More at www.bgandg.com\n\n\"Our practice centers on restoring investor capital and ensuring corporate\naccountability, which serves to uphold the essential integrity of the\nmarketplace,\" said Peretz Bronstein\n(https://www.linkedin.com/in/peretz-bronstein-65a1b411), Founding Partner of\nBronstein, Gewirtz & Grossman, LLC.\n\nFollow us for updates on LinkedIn\n(https://www.linkedin.com/company/bronstein-gewirtz-&-grossman-llc/), X\n(https://x.com/bgandg_law), Facebook (https://www.facebook.com/BGandG/), or\nInstagram (https://www.instagram.com/bg_and_g/).\n\nContact Info\n\nPeretz Bronstein, Esq. or Nathan Miller\nBronstein, Gewirtz & Grossman, LLC\n917-590-0911 (tel:+9175900911) | info@bgandg.com\n\nAttorney advertising.\n\nPrior results do not guarantee similar outcomes.\n\nSOURCE: Bronstein, Gewirtz & Grossman, LLC\nView the original press release\n(https://www.accessnewswire.com/newsroom/en/business-and-professional-services/medp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1155651)\non ACCESS Newswire\n\n\nCopyright 2026 ACCESS Newswire. All Rights Reserved."},"type":"article","timestamp":"2026-05-05T11:00:02.652944461Z","server_sent_at_ms":1777978802652},"received_at":"2026-05-05T11:00:02.704Z","source_url":"https://www.accessnewswire.com/newsroom/en/business-and-professional-services/medp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-1155651"},"analysis":{"id":"15297","press_release_id":"20720","analysis_json":{"industry":{"label":"Health Care Equipment & Services","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Bronstein, Gewirtz & Grossman, LLC issued a shareholder-solicitation notice regarding a class action lawsuit against Medpace Holdings, Inc. concerning alleged federal securities law violations.\n\nThe lawsuit claims Medpace made materially false statements about its book-to-bill ratio between April 22, 2025, and February 9, 2026.\n\nAffected investors have until June 5, 2026, to move for lead plaintiff status; this release is a law-firm solicitation, not an issuer disclosure.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace","namedEntities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Medpace Holdings, Inc.","ticker":"MEDP","relationship":"target"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Bronstein, Gewirtz & Grossman. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"MEDP"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Bronstein, Gewirtz & Grossman, LLC issued a shareholder-solicitation notice regarding a class action lawsuit against Medpace Holdings, Inc. concerning alleged federal securities law violations.\n\nThe lawsuit claims Medpace made materially false statements about its book-to-bill ratio between April 22, 2025, and February 9, 2026.\n\nAffected investors have until June 5, 2026, to move for lead plaintiff status; this release is a law-firm solicitation, not an issuer disclosure.","key_figures":{},"named_entities":{"people":[{"name":"Peretz Bronstein","role":"Founding Partner"},{"name":"Nathan Miller","role":"Client Relations Manager"}],"products":[],"companies":[{"name":"Bronstein, Gewirtz & Grossman, LLC","relationship":"plaintiff law firm"},{"name":"Medpace Holdings, Inc.","ticker":"MEDP","relationship":"target"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:a2703c5a1b5285fe","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-05-05T12:04:09.833Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":76613,"modelName":"glm-4.7"}}